Combination therapy for gonorrhoea: In vitro synergy testing

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 3, 2013, Pages 640-643

  Pereira, Rui ^a   Cole, Michelle J ^a   Ison, Catherine A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Azithromycin; Cefixime; Ceftriaxone; Gentamicin; Neisseria gonorrhoeae

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; GENTAMICIN;

AGAR DILUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SCREENING; GONORRHEA; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; DRUG SYNERGISM; GENTAMICINS; GONORRHEA; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE;

EID: 84873602520     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks449     Document Type: Article

References (12)

1. Van de Laar M, Spiteri G. Increasing trends of gonorrhoea and syphilis and the threat of drug-resistant gonorrhoea in Europe. Euro Surveill 2012; 17: pii=20225.
2. Whiley DM, Goire N, Lahra MM et al. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother 2012; 67: 2059-61.
3. Cámara J, Serra J, Ayats J et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 2012; 67: 1858-60.
4. Chisholm SA, Mouton JW, Lewis DA et al. Cephalosporin MIC creep among gonococci: Time for a pharmacodynamic rethink? J Antimicrob Chemother 2010; 65: 2141-8.
5. Bignell C, Fitzgerald M. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS 2011; 22: 541-7.
6. Ross JD, Lewis DA. Cephalosporin resistant Neisseria gonorrhoeae: time to consider gentamicin? Sex Transm Infect 2012; 88: 6-8.
7. Chisholm SA, Quaye N, Cole MJ et al. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother 2010; 66: 592-5.
8. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V, ed. Antibiotics in Laboratory Medicine. Baltimore, MD: Williams and Wilkins, 1996; 330-96.
9. Furuya R, Nakayama H, Kanayama A et al. In vitro synergistic effects of double combinations of β-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. J Infect Chemother 2006; 12: 172-6.
10. Onodera S, Kiyota H, Endo K et al. Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefiximeresistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin. J Infect Chemother 2006; 12: 207-9.
11. Jia J, Zhu F, Ma X et al. Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov 2009; 8: 111-28.
12. Hsieh MH, Yu CM, Yu VL et al. Synergy assessed by checkerboard. A critical analysis. Diagn Microbiol Infect Dis 1993; 16: 343-9.